Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis
Vladimir Bilim(Kameda Medical Center), Yoshihiko Tomita(Niigata University Medical and Dental Hospital)
Cited by 49
Related Papers
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
|British Journal of Cancer|2009|107
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
|Scientific Reports|2019|60
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells
|Current Oncology|2023|3
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma
|Current Issues in Molecular Biology|2023|2